4th International Conference on Mind-Body & Medicine in Endocrinology & Diabetes


Rules for Submission

Registration for conference is compulsory prior to abstract submission Please read the submission rules before submitting an abstract.
  • Abstracts must be submitted in word format, via abstract registration.
  • Abstracts may be submitted for Oral or Poster Presentations.
  • Date will be announce soon to submit abstracts. Abstracts received after the deadline will not be considered.


  • Previous publications of an abstract – if it was presented in any other conference earlier, then it cannot be submitted unless there is significant new data.
  • The same person may submit up to 5 abstracts regardless of presenting author.
  • The same person may serve as presenting author on up to 5 abstracts. However, for oral presentations, one author can present only one.
  • Presenting author must be registered participant. Only abstracts of authors who have their registration process completed, by the abstract submission deadline (Date will be announce soon), will be considered for review.
  • Submission of an abstract acknowledges your acceptance for the abstract to be used by SPHERE for academic purposes.
  • The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract. In case of any dispute, the abstracts might be dropped from the conference proceedings.
  • All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.
  • Disclosure of Conflicts of Interest – Abstract submitters should disclose any conflict of interests while submitting the abstract.

Abstract Topic

  • Hormones and Mind Health
  • Diabetes and Mind Health
  • Health Psychology
  • Quality of Care
  • Mental Health to Improve Outcomes in Endocrine Disease

Guidelines for Submission

  • All abstracts are subject to review by the Scientific Program Committee.
  • Abstracts must be submitted according to guidelines given below.
  • Abstracts should be prepared and submitted as a Word document to via abstract login.
  • Please use ‘Calibri’ font. The font size should be 11 points or bigger.
Preferred presentation type should be clearly mention.
  • Oral Presentation will be in physical mode
  • Poster Presentation will be virtual /physical
However, the scientific committee reserves the right to accept/ reject/ assign a different presentation type to all the abstracts submitted. Abstract Title
  • Please write the title in UPPER CASE and should be limited to 30 words.
  • Leave one blank line between the title and authors/ affiliations.
Abstract Text
  • Abstract should be limited to 500 words including acknowledgements (if any).
  • The abstract may include one table or graph or picture.
  • Abstracts that merely state the results which will be presented, will be subject to rejection.
  • Abstracts should clearly state the following;
    • Background and Aims
    • Methods
    • Results
    • Conclusions
  • Use only standard abbreviations. Abbreviations must be consistent and be defined on 1st usage, then use of abbreviation.
  • Use generic names of drugs (if any). The presentation must be balanced and contain no commercial promotional content.
  • Do not begin sentences with a number – type the number in full, for example, it should be ‘Three patients….’ Instead of ‘3 patients….’.
  • An acknowledgment with an identification (unique) number shall be shared with you on receipt of your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
  • Please contact us if you have not received confirmation that your abstract has been submitted.
  • Please do not submit multiple copies of the same abstract.
  • If the application is not sent in the prescribed format (as mentioned above), it will not be considered for review.

Withdrawal of presentation should be intimated to the conference secretariat on or before
Date will be announce soon.

Learning Objectives: